<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="NEW YORK, NY / ACCESSWIRE / May 6, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.” data-reactid=”12″>NEW YORK, NY / ACCESSWIRE / May 6, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Cronos Group Inc. (CRON)
Class Period: May 9, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 11, 2020″ data-reactid=”13″>Cronos Group Inc. (CRON)
Class Period: May 9, 2019 to March 2, 2020
Lead Plaintiff Deadline: May 11, 2020
The complaint alleges that throughout the class period Cronos Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company’s ability to timely file its periodic reports; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in CRON: http://www.kleinstocklaw.com/pslra-1/cronos-group-inc-loss-submission-form-2?id=6393&from=1” data-reactid=”15″>Learn about your recoverable losses in CRON: http://www.kleinstocklaw.com/pslra-1/cronos-group-inc-loss-submission-form-2?id=6393&from=1
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Gossamer Bio, Inc. (GOSS)
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline: June 2, 2020″ data-reactid=”16″>Gossamer Bio, Inc. (GOSS)
Class Period: common stock between February 8, 2019 and December 13, 2019 and/or who acquired Gossamer shares pursuant or traceable to Gossamer’s documents issued in connection with its February 8, 2019 initial public offering.
Lead Plaintiff Deadline: June 2, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer’s GB001 trial failures; (2) the purported clinical validation of Novartis’ oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in GOSS: http://www.kleinstocklaw.com/pslra-1/gossamer-bio-inc-loss-submission-form?id=6393&from=1” data-reactid=”18″>Learn about your recoverable losses in GOSS: http://www.kleinstocklaw.com/pslra-1/gossamer-bio-inc-loss-submission-form?id=6393&from=1
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="eHealth, Inc. (EHTH)
Class Period: March 19, 2018 to April 7, 2020
Lead Plaintiff Deadline: June 8, 2020″ data-reactid=”19″>eHealth, Inc. (EHTH)
Class Period: March 19, 2018 to April 7, 2020
Lead Plaintiff Deadline: June 8, 2020
The complaint alleges that eHealth, Inc. issued materially false and/or misleading information and/or failed to disclose: (1) its highly aggressive accounting and modeling assumptions; (2) its skyrocketing rate of member churn, resulting from eHealth’s pursuit of low quality, lossmaking growth; (3) its reliance on direct response television advertising, which attracts an unprofitable, high churn enrollee; and (4) that as a result of the foregoing, defendants’ public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Learn about your recoverable losses in EHTH: http://www.kleinstocklaw.com/pslra-1/ehealth-inc-loss-submission-form?id=6393&from=1” data-reactid=”21″>Learn about your recoverable losses in EHTH: http://www.kleinstocklaw.com/pslra-1/ehealth-inc-loss-submission-form?id=6393&from=1
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:” data-reactid=”24″>CONTACT:
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com” data-reactid=”25″>J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
[email protected]
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SOURCE: The Klein Law Firm” data-reactid=”26″>SOURCE: The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/588809/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CRON-GOSS-and-EHTH
Add Comment